8 marzo 2024 anni - Wegovy Approved by The FDA
Descrizione:
The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.
Aggiunto al nastro di tempo:
Data:
~ 1 years and 3 months ago